10 things you must know before the opening bell on April 22

Market

Updated: April 22, 2021 07:46 AM IST

The Indian market is likely to open on a cautionary note on Thursday on concerns over the second wave of COVID-19 in the country and tightening restrictions in various provinces. Meanwhile, the Nifty SGX was trading at around 14,156 compared to Tuesday’s Nifty Futures close of 14,296.

    1. Wall Street: Stocks ended roughly higher on Wall Street after gaining steadily throughout the day.  The S&P 500 index added 0.9 percent on Wednesday following its first back-to-back loss since March.  The Dow Jones Industrial Average rose 0.9 percent and the Nasdaq 1.2 percent.

1. Wall Street: Stocks ended up higher on Wall Street after gaining steadily throughout the day. The S&P 500 index added 0.9 percent on Wednesday following its first back-to-back loss since March. The Dow Jones Industrial Average rose 0.9 percent and the Nasdaq 1.2 percent.

    2. Asian Stocks: Stocks in Asia-Pacific rose Thursday following an overnight bounce on Wall Street.  The Nikkei 225 in Japan jumped 1.2 percent in early trade, partially recovering after two days of losses earlier in the week.  Shares in Australia edged higher as the S & P / ASX 200 rose 0.21 per cent.  MSCI's broadest index of Asia-Pacific stocks outside Japan traded 0.07 percent higher.

2. Asian stocks: Stocks in Asia-Pacific rose Thursday following an overnight bounce on Wall Street. The Nikkei 225 in Japan jumped 1.2 percent in early trade, partially recovering after two days of losses earlier in the week. Shares in Australia edged higher as the S & P / ASX 200 rose 0.21 per cent. MSCI’s widest index of Asia-Pacific stocks outside Japan traded 0.07 percent higher.

    3. Dalal Street: India's equity, currency, debt and commodity markets closed on Wednesday due to Ram Navami.

3. Dalal Street: India’s equity, currency, debt and commodity markets closed on Wednesday due to Ram Navami.

    4. Oil: Oil prices have been weighed down by concerns that the surge of COVID-19 outbreaks in India will reduce fuel demand at the world's third-largest oil importer.  U.S. crude recently fell 1.1 percent to $ 61.99 a barrel and Brent was at $ 65.97, down 0.9 percent on the day.

4. Oil: Oil prices have been weighed down by concerns that the surge of COVID-19 outbreaks in India will reduce fuel demand as the world’s third-largest oil importer. U.S. crude recently fell 1.1 percent to $ 61.99 a barrel and Brent was at $ 65.97, down 0.9 percent on the day.

    5. Rupee: The rupee cut its initial earnings to close down 1 paisa at 74.88 against the US dollar on Tuesday due to concerns that the alarming surge in COVID-19 cases could undo the economic recovery in the country.

5. Rupee: The rupee cut its initial earnings to close down 1 paisa at 74.88 against the US dollar on Tuesday due to concerns that the alarming surge in COVID-19 cases could undo the economic recovery in the country.

    6. Gold: Gold jumped 1 percent on Wednesday driven by slipping US Treasury yields, while bets for auto-catalyst palladium metal supply shortfalls are powered to an all-time high.

6. Gold: Gold jumped 1 percent on Wednesday driven by slipping US Treasury yields, while bets for auto-catalyst palladium metal supply shortfalls are powering to record levels.

    7. FPIs: The value of foreign portfolio investor holdings (FPIs) in domestic equity reached an all-time high of $ 555 billion in 2020-21, a staggering $ 105 billion growth between September 2020 and March 2021. Read more

7. FPIs: The value of foreign portfolio investor (FPI) holdings in domestic equity reached an all-time high of $ 555 billion in 2020-21, a staggering $ 105 billion growth between September 2020 and March 2021. Read more

    8. Finance: Listed companies topped Rs 7.72 lakh crore by issuing bonds based on private placement in 2020-21, an increase of 14 per cent from the previous fiscal, backed by low interest rate and excess liquidity in the system.  Read more

8. Finance: Listed companies topped Rs 7.72 lakh crore by issuing bonds based on private placement in 2020-21, an increase of 14 per cent from previous fiscal, backed by low interest rate and excess liquidity in the system. Read more

    9. LIC: The Life Insurance Corporation of India (LIC) collected new premiums worth Rs 1.84 lakh crore in FY21, which is the highest ever even as most businesses are affected by COVID lockup.  This is up 3.4 per cent or about Rs 1.77 lakh crore.  Read more

9. LIC: Life Insurance Corporation of India (LIC) collected new premiums worth Rs 1.84 lakh crore in FY21, which is the highest ever even as most businesses are affected by COVID lockup. This is up 3.4 per cent or about Rs 1.77 lakh crore. Read more

    10. COVID-19: Bharat Biotech and the Medical Research Council of India (ICMR) - developers of the Covaxin native COVID-19 vaccine - have claimed that their vaccine has shown overall temporary clinical efficacy of 78 percent and 100 percent efficacy against disease COVID-19 severe.  Read more

10. COVID-19: Bharat Biotech and the Medical Research Council of India (ICMR) – developers of the native COVID-19 Covaxin vaccine – have claimed that their vaccine has shown overall temporary clinical efficacy of 78 percent and 100 percent efficacy against severe COVID-19 disease. Read more

Published: April 22, 2021 07:46 AM IST




Advertisement

Source